Sell:45.30pBuy:45.45p1.70p (3.88%)
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
---|---|---|---|---|---|---|
11 December 2024 | Hayleigh LupinoCFO | Buy Regular purchase transaction | 45,736 | £0.43 | £19,886.01 | 215,742 |
2 August 2024 | Rachel Claire Elizabeth OsborneIndependent Director | Buy Regular purchase transaction | 62,177 | £0.40 | £24,870.80 | 141,067 |
25 July 2024 | Kenneth (Ken) LeverChairman of the Board | Buy Regular purchase transaction | 280,000 | £0.38 | £107,156.00 | 280,000 |
13 March 2024 | Justin Mark PlattCEO | Buy Regular purchase transaction | 347,886 | £0.29 | £99,495.40 | 347,886 |
31 January 2024 | Rachel Claire Elizabeth OsborneIndependent Director | Buy Regular purchase transaction | 78,890 | £0.32 | £24,874.02 | 78,890 |
Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
---|---|---|---|---|---|---|
25 July 2024 | Kenneth (Ken) LeverChairman of the Board | Buy Regular purchase transaction | 280,000 | £0.38 | £107,156.00 | 280,000 |
13 March 2024 | Justin Mark PlattCEO | Buy Regular purchase transaction | 347,886 | £0.29 | £99,495.40 | 347,886 |
31 January 2024 | Rachel Claire Elizabeth OsborneIndependent Director | Buy Regular purchase transaction | 78,890 | £0.32 | £24,874.02 | 78,890 |
2 August 2024 | Rachel Claire Elizabeth OsborneIndependent Director | Buy Regular purchase transaction | 62,177 | £0.40 | £24,870.80 | 141,067 |
11 December 2024 | Hayleigh LupinoCFO | Buy Regular purchase transaction | 45,736 | £0.43 | £19,886.01 | 215,742 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.